Rumors of a Smith & Nephew takeout have swirled for years, but two recent business developments make a potential merger seem more likely.
Medical Device Business
Naglreiter Medical Device Development Organization uses a novel approach to shorten the timeline between medical device concept and device submission.
NuVasive says former exec Patrick Miles schemed for more than a year to disparage the company before jumping ship. Alphatec calls the lawsuit a "frivolous PR stunt."
Developing a medical device and looking to take it to the next level? Join our tour of the MD&M Minneapolis show floor to meet the top medtech innovators in the industry. Below we share the five MD&M Minneapolis exhibitors selected for the tour by the MD+DI editorial team.
The company plans to boost its growth prospects through a $225 million acquisition of Jotec, but disappointing earnings news drove its shares down anyway.
Value-based care and the potential for a corporate tax holiday are a couple of the big topics in the medtech policy spotlight. Here’s how these issues could impact medical device companies.
Medtronic is already bracing for a rough second-quarter earnings report in the aftermath of Hurricane Maria, could California’s wildfires cause further destruction to the company’s bottom line?
Nikhil Murdeshwar, the principal research engineer at Olympus Surgical, shares a few tips on how to develop a low-cost, high-impact R&D budget.
Steve Geist, director of R&D at Edwards Lifesciences’ transcatheter mitral and tricuspid therapies division, talks about how and why innovation can and should be done at a startup pace within larger companies.
Johnson & Johnson plans to shut down Animas Corp., and the nearly 90,000 patients using its insulin pumps will have the option to transfer to Medtronic pumps.
Boston Scientific is acquiring Apama Medical for up to $300 million, a deal that should help the company’s EP business hit its stride.
Medtech startups are struggling to secure funding in the early phases of development. Here’s what large companies, venture capital, and startups can do to combat this troubling trend.
Wondering how your salary stacks up against that of your medtech peers? Learn more with the results of our 2017 Medtech Salary Survey.
With Alere’s DOJ investigation and FTC approval finally in the rearview mirror, Abbott said it plans to close the Alere acquisition Tuesday.